Trademark Overview
On Monday, February 3, 2025, a trademark application was filed for ZARMENY with the United States Patent and Trademark Office. The USPTO has given the ZARMENY trademark a serial number of 99026925. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, February 3, 2025. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The ZARMENY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy